Market Cap 79.49M
Revenue (ttm) 48.47M
Net Income (ttm) -170.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -351.50%
Debt to Equity Ratio 0.00
Volume 2,674,400
Avg Vol 9,150,156
Day's Range N/A - N/A
Shares Out 234.70M
Stochastic %K 40%
Beta 2.15
Analysts Sell
Price Target $3.80

Company Profile

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to devel...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 684 1300
Address:
3115 Merryfield Row, Suite 120, San Diego, United States
sv__
sv__ May. 12 at 7:23 PM
$GOSS Amount of shares tripled down. No risk, no fun!😅
1 · Reply
Biotechs5454
Biotechs5454 May. 12 at 6:44 PM
$GOSS grabbed 250k today to start. High risk high reward. Positive type c meeting and we have a runner IMHo.
0 · Reply
AlexRo777
AlexRo777 May. 12 at 4:54 PM
$GOSS when this trash has earnings?!
0 · Reply
I_Hate_Stock_Twits
I_Hate_Stock_Twits May. 12 at 7:30 AM
$GOSS , Finn, remember the analyst that said that if she had PAH she'd like to be on GOSS. That was months after LQDA got approval and began with sales. If she's correct LQDA is toast.
1 · Reply
Finnish_boy
Finnish_boy May. 11 at 10:04 PM
$GOSS I studied LQDA (PAH/PH-ILD also) at the same time when i invested in GOSS at $1. LQDA looked amazing revenue ramp up setup. It had litigation risk (UTHR) though. GOSS $1->$0.3 and LQDA $12->$50. Am i stupid? Yes.
1 · Reply
Finnish_boy
Finnish_boy May. 11 at 9:56 PM
$GOSS CT imaging data with earnings. At least they tell when it will be out. I think this month for sure.
0 · Reply
afgncap
afgncap May. 11 at 7:22 PM
$GOSS so at this point the CT information should have already come in (just on the timeline projection from march, post data readout). The side hope is that it came in, concrete evidence that the drug is dilating blood vessels, and they are already working with FDA on why this should overrule the outlier placebo cases that caused the trial to come in just over stat sig. May is hopium month
1 · Reply
k1nglogman
k1nglogman May. 11 at 3:48 PM
0 · Reply
Partyflags
Partyflags May. 8 at 1:06 PM
0 · Reply
Hahaha111
Hahaha111 May. 7 at 6:11 PM
$GDC this is reminding me of $GOSS which is concerning cos it never went up like everyone thought it would
1 · Reply
Latest News on GOSS
Gossamer Bio reports Q4 EPS (21c), consensus (20c)

2026-03-17T20:05:29.000Z - 2 months ago

Gossamer Bio reports Q4 EPS (21c), consensus (20c)


Gossamer Bio price target lowered to $3 from $12 at Oppenheimer

2026-03-05T13:28:33.000Z - 2 months ago

Gossamer Bio price target lowered to $3 from $12 at Oppenheimer


Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs

2026-02-24T23:20:17.000Z - 2 months ago

Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs


Wedbush downgrades Gossamer Bio to Neutral, lowers target to $1

2026-02-24T12:57:11.000Z - 2 months ago

Wedbush downgrades Gossamer Bio to Neutral, lowers target to $1


Gossamer Bio downgraded to Neutral from Outperform at Wedbush

2026-02-24T12:20:19.000Z - 2 months ago

Gossamer Bio downgraded to Neutral from Outperform at Wedbush


Gossamer Bio Transcript: Study result

Feb 23, 2026, 8:30 AM EST - 2 months ago

Gossamer Bio Transcript: Study result


Gossamer Bio to Participate in Upcoming Investor Conferences

Nov 24, 2025, 4:01 PM EST - 6 months ago

Gossamer Bio to Participate in Upcoming Investor Conferences


Gossamer Bio Transcript: Emerging Growth Conference

Oct 23, 2025, 3:40 PM EDT - 7 months ago

Gossamer Bio Transcript: Emerging Growth Conference


Gossamer Bio to Present at Upcoming Investor Conferences

Aug 29, 2025, 7:31 AM EDT - 9 months ago

Gossamer Bio to Present at Upcoming Investor Conferences


Gossamer Bio Transcript: Emerging Growth Conference 82

May 22, 2025, 4:25 PM EDT - 1 year ago

Gossamer Bio Transcript: Emerging Growth Conference 82


Gossamer Bio Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Gossamer Bio Earnings Call Transcript: Q1 2025


Gossamer Bio Transcript: Emerging Growth Conference 79

Feb 19, 2025, 12:00 PM EST - 1 year ago

Gossamer Bio Transcript: Emerging Growth Conference 79


Gossamer Bio Transcript: M&A Announcement

May 6, 2024, 8:30 AM EDT - 2 years ago

Gossamer Bio Transcript: M&A Announcement


Gossamer Bio Announces Appointment of Steven D. Nathan, M.D.

Mar 12, 2024, 7:31 AM EDT - 2 years ago

Gossamer Bio Announces Appointment of Steven D. Nathan, M.D.


Gossamer Bio Transcript: Study Update 2023

Dec 18, 2023, 8:30 AM EST - 2 years ago

Gossamer Bio Transcript: Study Update 2023


sv__
sv__ May. 12 at 7:23 PM
$GOSS Amount of shares tripled down. No risk, no fun!😅
1 · Reply
Biotechs5454
Biotechs5454 May. 12 at 6:44 PM
$GOSS grabbed 250k today to start. High risk high reward. Positive type c meeting and we have a runner IMHo.
0 · Reply
AlexRo777
AlexRo777 May. 12 at 4:54 PM
$GOSS when this trash has earnings?!
0 · Reply
I_Hate_Stock_Twits
I_Hate_Stock_Twits May. 12 at 7:30 AM
$GOSS , Finn, remember the analyst that said that if she had PAH she'd like to be on GOSS. That was months after LQDA got approval and began with sales. If she's correct LQDA is toast.
1 · Reply
Finnish_boy
Finnish_boy May. 11 at 10:04 PM
$GOSS I studied LQDA (PAH/PH-ILD also) at the same time when i invested in GOSS at $1. LQDA looked amazing revenue ramp up setup. It had litigation risk (UTHR) though. GOSS $1->$0.3 and LQDA $12->$50. Am i stupid? Yes.
1 · Reply
Finnish_boy
Finnish_boy May. 11 at 9:56 PM
$GOSS CT imaging data with earnings. At least they tell when it will be out. I think this month for sure.
0 · Reply
afgncap
afgncap May. 11 at 7:22 PM
$GOSS so at this point the CT information should have already come in (just on the timeline projection from march, post data readout). The side hope is that it came in, concrete evidence that the drug is dilating blood vessels, and they are already working with FDA on why this should overrule the outlier placebo cases that caused the trial to come in just over stat sig. May is hopium month
1 · Reply
k1nglogman
k1nglogman May. 11 at 3:48 PM
0 · Reply
Partyflags
Partyflags May. 8 at 1:06 PM
0 · Reply
Hahaha111
Hahaha111 May. 7 at 6:11 PM
$GDC this is reminding me of $GOSS which is concerning cos it never went up like everyone thought it would
1 · Reply
I_Buy_Stock
I_Buy_Stock May. 7 at 5:58 PM
$SLS Everyone point and laugh at this clown trying to act like he knows even one single piece of information about REGAL who is trying to say what happened to $GOSS would happen to us.
2 · Reply
King_of_Bio
King_of_Bio May. 7 at 1:29 PM
0 · Reply
SuperGreenToday
SuperGreenToday May. 6 at 5:41 PM
$GOSS Share Price: $0.35 Contract Selected: Nov 20, 2026 $0.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 53% ROI Time to Expiration: 197 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
I_Hate_Stock_Twits
I_Hate_Stock_Twits May. 6 at 8:11 AM
$GOSS Frankly, I think that mismanagement is always the best reason to go after a company. This stumble is not a fall. I doubt that company officers wanted to have things go south at one of their sites (though that's always possible). Yes this could be some quasi-insider gambit--I've always thought companies always have to deal with disreputable whales... Either way there appears to be opportunity here for the patient investor.
0 · Reply
financiallylacking
financiallylacking May. 5 at 4:42 PM
$GOSS Any chance Chiesi will make a move on this now?
0 · Reply
Southshd
Southshd May. 5 at 2:58 PM
$GOSS 500k shares .333 👍
0 · Reply
Southshd
Southshd May. 5 at 2:57 PM
$GOSS added again today 500k shares 33.3
0 · Reply
Havokmdk
Havokmdk May. 5 at 11:59 AM
$GOSS sell the company
0 · Reply
MicsMugz
MicsMugz May. 5 at 2:54 AM
$GOSS Load up and then send me my cut after. Thanks my pleasure
0 · Reply
King_of_Bio
King_of_Bio May. 4 at 6:12 PM
$GOSS Nothing to see here..move along.
0 · Reply
Finnish_boy
Finnish_boy May. 4 at 3:50 PM
0 · Reply
PepCF
PepCF May. 4 at 11:09 AM
0 · Reply